42 related articles for article (PubMed ID: 19928858)
1. Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.
You W; Chang CA
J Chem Inf Model; 2018 May; 58(5):968-981. PubMed ID: 29620886
[TBL] [Abstract][Full Text] [Related]
2. A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.
Li J; Kaoud TS; LeVieux J; Gilbreath B; Moharana S; Dalby KN; Kerwin SM
Chembiochem; 2013 Jan; 14(1):66-71. PubMed ID: 23225637
[TBL] [Abstract][Full Text] [Related]
3. Multiscale computational study of ligand binding pathways: Case of p38 MAP kinase and its inhibitors.
Huang YM
Biophys J; 2021 Sep; 120(18):3881-3892. PubMed ID: 34453922
[TBL] [Abstract][Full Text] [Related]
4. Computational generation inhibitor-bound conformers of p38 MAP kinase and comparison with experiments.
Bakan A; Bahar I
Pac Symp Biocomput; 2011; ():181-92. PubMed ID: 21121046
[TBL] [Abstract][Full Text] [Related]
5. Classifying protein kinase conformations with machine learning.
Reveguk I; Simonson T
Protein Sci; 2024 Apr; 33(4):e4918. PubMed ID: 38501429
[TBL] [Abstract][Full Text] [Related]
6. Profiling MAP kinase cysteines for targeted covalent inhibitor design.
Liu R; Verma N; Henderson JA; Zhan S; Shen J
RSC Med Chem; 2022 Jan; 13(1):54-63. PubMed ID: 35224496
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families.
Li L; Meyer C; Zhou ZW; Elmezayen A; Westover K
J Mol Biol; 2022 Sep; 434(17):167626. PubMed ID: 35595166
[TBL] [Abstract][Full Text] [Related]
8. Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia.
Musumeci F; Greco C; Grossi G; Molinari A; Schenone S
Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30423915
[TBL] [Abstract][Full Text] [Related]
9. Paroxetine is a direct inhibitor of g protein-coupled receptor kinase 2 and increases myocardial contractility.
Thal DM; Homan KT; Chen J; Wu EK; Hinkle PM; Huang ZM; Chuprun JK; Song J; Gao E; Cheung JY; Sklar LA; Koch WJ; Tesmer JJ
ACS Chem Biol; 2012 Nov; 7(11):1830-9. PubMed ID: 22882301
[TBL] [Abstract][Full Text] [Related]
10. Insights from free-energy calculations: protein conformational equilibrium, driving forces, and ligand-binding modes.
Huang YM; Chen W; Potter MJ; Chang CE
Biophys J; 2012 Jul; 103(2):342-51. PubMed ID: 22853912
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a potential allosteric ligand binding site in CDK2.
Betzi S; Alam R; Martin M; Lubbers DJ; Han H; Jakkaraj SR; Georg GI; Schönbrunn E
ACS Chem Biol; 2011 May; 6(5):492-501. PubMed ID: 21291269
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
[TBL] [Abstract][Full Text] [Related]
13. Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations.
Simard JR; Getlik M; Grütter C; Schneider R; Wulfert S; Rauh D
J Am Chem Soc; 2010 Mar; 132(12):4152-60. PubMed ID: 20201574
[TBL] [Abstract][Full Text] [Related]
14. FLiK: a direct-binding assay for the identification and kinetic characterization of stabilizers of inactive kinase conformations.
Simard JR; Rauh D
Methods Enzymol; 2014; 548():147-71. PubMed ID: 25399645
[TBL] [Abstract][Full Text] [Related]
15. Novel strategies for inhibition of the p38 MAPK pathway.
Zhang J; Shen B; Lin A
Trends Pharmacol Sci; 2007 Jun; 28(6):286-95. PubMed ID: 17482683
[TBL] [Abstract][Full Text] [Related]
16. Displacement assay for the detection of stabilizers of inactive kinase conformations.
Klüter S; Grütter C; Naqvi T; Rabiller M; Simard JR; Pawar V; Getlik M; Rauh D
J Med Chem; 2010 Jan; 53(1):357-67. PubMed ID: 19928858
[TBL] [Abstract][Full Text] [Related]
17. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
